1. Home
  2. Active Ingredient Index
  3. Bevacizumab

Active Ingredient Bevacizumab

Active Ingredient Details

What is Bevacizumab?

An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.

What is the usage for Bevacizumab?

This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.

How many products in the NDC database contain Bevacizumab?

The NDC database has 15 products with the active ingredient Bevacizumab. The following table lists all the products that have this active ingredient.

NDC Products with Bevacizumab

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0069-0315Proprietary Name: Zirabev Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
0069-0342Proprietary Name: Zirabev Bevacizumab-bvzrInjection, SolutionIntravenousPfizer Laboratories Div Pfizer IncACTIVE
50242-059Proprietary Name: BevacizumabLiquidGenentech, Inc.ACTIVE
50242-060Proprietary Name: Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-061Proprietary Name: Avastin BevacizumabInjection, SolutionIntravenousGenentech, Inc.ACTIVE
50242-160Proprietary Name: BevacizumabLiquidGenentech, Inc. (ssf)ACTIVE
55513-206Proprietary Name: Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
55513-207Proprietary Name: Mvasi Bevacizumab-awwbInjection, SolutionIntravenousAmgen IncACTIVE
58394-095Proprietary Name: BevacizumabLiquidWyeth Biopharma Division Of Wyeth Pharmaceuticals LlcACTIVE
63552-113Proprietary Name: BevacizumabInjection, SolutionPatheon Manufacturing Services LlcACTIVE
63552-114Proprietary Name: BevacizumabInjection, SolutionPatheon Manufacturing Services LlcACTIVE
70121-1754Proprietary Name: Alymsys Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
70121-1755Proprietary Name: Alymsys Bevacizumab-malyInjection, SolutionIntravenousAmneal Pharmaceuticals LlcACTIVE
72606-011Proprietary Name: Vegzelma Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
72606-012Proprietary Name: Vegzelma Bevacizumab-adcdInjection, SolutionIntravenousCelltrion Usa, Inc.ACTIVE
<